glp 1 mounjaro GLP-1 Weight Loss Treatments: Ozempic, Mounjaro, and Other Options| PMN What You Need to Know

After noticing about half of users stop taking GLP-1s shortly after starting treatment, Al-Aly wanted to understand the consequences of discontinuing GLP-1 medications on cardiovascular health, particularly the risk of major adverse cardiovascular events, including heart attack, stroke and death

aPhase 2 randomized clinical trials

Start gathering these materials now, even before you contact an attorney

The effects of GLP-1 medications may not be permanent

Data extraction An EndNote X9 (Clarivate Analytics, London, UK) library was initially created

In general, weight-loss medications are only recommended for patients with a baseline body mass index (BMI) of 30 kg/m2 or higher (obesity) or 27 kg/m2 or higher (overweight) AND at least one of the following weight-related conditions: Cardiovascular disease High blood pressure High cholesterol Type 2 diabetes Obstructive sleep apnea Regardless of whether a weight loss medication is recommended, a balanced diet and adequate exercise are generally recommended in conjunction with Ozempic